$LIEN
Chicago Atlantic BDC, Inc. Stock $lien

$lien Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000114036123024271 Filed on May 12, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q4
Revenue	$1.899M	$1.371M	$2.047M
YoY Change	134.61%	-735.97%
Cost Of Revenue	$733.2K	$669.9K	$183.1K
YoY Change	523.49%
Gross Profit	$2.161M	$1.788M	$1.864M
YoY Change	212.22%
Gross Profit Margin	113.75%	130.44%	91.05%
Selling, General & Admin	$378.5K	$397.7K	$395.9K
YoY Change	-9.45%
% of Gross Profit	17.52%	22.24%	21.24%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$261.1K	$417.2K	$438.2K
YoY Change	-44.53%
Operating Profit	$1.899M	$1.371M	$1.425M
YoY Change	758.49%
Interest Expense	-$688.0K	$986.4K	-$273.4K
YoY Change	7134.6%
% of Operating Profit	-36.22%	71.96%	-19.18%
Other Income/Expense, Net
YoY Change
Pretax Income	$1.211M	$2.357M	$1.152M
YoY Change	472.12%
Income Tax
% Of Pretax Income
Net Earnings	$1.211M	$2.357M	$1.152M
YoY Change	472.12%	-97.23%
Net Earnings / Revenue	63.78%	171.96%	56.29%
Basic Earnings Per Share	$0.19	$0.38
Diluted Earnings Per Share	$0.19	$0.38	$0.19
COMMON SHARES
Basic Shares Outstanding	6.215M	6.215M
Diluted Shares Outstanding	6.215M	6.215M

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$32.90M	$32.54M	$35.13M
YoY Change	-45.73%
Cash & Equivalents	$32.90M	$32.54M	$35.13M
Short-Term Investments
Other Short-Term Assets	$179.7K	$254.7K	$32.32K
YoY Change	-13.31%
Inventory
Prepaid Expenses
Receivables
Other Receivables			$0.00
Total Short-Term Assets	$33.67M	$34.37M	$36.72M
YoY Change	-44.71%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$57.67M	$55.62M	$50.25M
YoY Change	136.18%
Other Assets
YoY Change
Total Long-Term Assets	$57.67M	$55.62M	$50.25M
YoY Change	136.18%
TOTAL ASSETS
Total Short-Term Assets	$33.67M	$34.37M	$36.72M
Total Long-Term Assets	$57.67M	$55.62M	$50.25M
Total Assets	$91.34M	$89.99M	$86.97M
YoY Change	7.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$0.00	$0.00	$80.57K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.292M	$1.157M	$495.6K
YoY Change	137.17%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change	-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.292M	$1.157M	$495.6K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$1.292M	$1.157M	$495.5K
YoY Change	136.78%
SHAREHOLDERS EQUITY
Retained Earnings	$4.943M	$3.732M	$1.496M
YoY Change
Common Stock	$62.15K	$62.15K	$62.15K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$90.04M	$88.83M	$86.48M
YoY Change
Total Liabilities & Shareholders Equity	$91.34M	$89.99M	$86.97M
YoY Change	7.06%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q4
OPERATING ACTIVITIES
Net Income	$1.211M	$2.357M	$1.152M
YoY Change	472.12%	-97.23%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	$351.6K	-$2.581M	-$25.93M
YoY Change	-101.46%	407.02%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid	$0.00	$0.00
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	0.000	0.000
YoY Change		-100.0%
NET CHANGE
Cash From Operating Activities	351.6K	-2.581M	-25.93M
Cash From Investing Activities
Cash From Financing Activities	0.000	0.000	0.000
Net Change In Cash	351.6K	-2.581M	-25.93M
YoY Change	-101.46%	-103.05%
FREE CASH FLOW
Cash From Operating Activities	$351.6K	-$2.581M	-$25.93M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001843162
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#MariMedIncMember
CY2022	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#ShryneGroupIncMember
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#CuraleafHoldingsIncMember
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#ShryneGroupIncMember
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#PharmaCannIncMember
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#AYRWellnessIncMember
CY2023Q1	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#VeranoHoldingsCorpMember
CY2022	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#CuraleafHoldingsIncMember
CY2022	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#VeranoHoldingsCorpMember
CY2022	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#AYRWellnessIncMember
CY2022	us-gaap-sup	Investment Issuer Name Extensible Enumeration InvestmentIssuerNameExtensibleEnumeration	http://silverspikecap.com/20230331#PharmaCannIncMember
CY2022Q4	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredFirstLienTermLoanMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2022Q4	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredFirstLienTermLoanMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredFirstLienTermLoanMember
CY2022Q4	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredFirstLienTermLoanMember
CY2023Q1	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredFirstLienTermLoanMember
CY2022Q4	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2022Q4	us-gaap-sup	Investment Type Extensible Enumeration InvestmentTypeExtensibleEnumeration	http://silverspikecap.com/20230331#SeniorSecuredNoteMember
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2022Q4	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2022Q4	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2022Q4	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2022Q4	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2022Q4	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Significant Unobservable Input InvestmentSignificantUnobservableInput	true
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#MidwestRegionMember
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#SoutheastRegionMember
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#MidwestRegionMember
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#NortheastRegionMember
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#WestRegionMember
CY2022Q4	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#SoutheastRegionMember
CY2022Q4	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#MidwestRegionMember
CY2022Q4	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#MidwestRegionMember
CY2022Q4	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#WestRegionMember
CY2023Q1	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#NortheastRegionMember
CY2022Q4	us-gaap-sup	Investment Issuer Geographic Region Extensible Enumeration InvestmentIssuerGeographicRegionExtensibleEnumeration	http://fasb.org/us-gaap-sup/2022q3#NortheastRegionMember
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Debt Securities Fair Value By Fair Value Hierarchy Level Extensible List DebtSecuritiesFairValueByFairValueHierarchyLevelExtensibleList	http://fasb.org/us-gaap/2022#FairValueInputsLevel3Member
CY2023Q1	us-gaap	Management Fee Payable ManagementFeePayable	409384
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	170965
CY2023Q1	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	203821
CY2022Q4	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	0
CY2023Q1	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	142602
CY2022Q4	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	0
CY2023Q1	ssic	Legal Fees Payable Current And Noncurrent LegalFeesPayableCurrentAndNoncurrent	99988
CY2022Q4	ssic	Legal Fees Payable Current And Noncurrent LegalFeesPayableCurrentAndNoncurrent	42215
CY2023Q1	ssic	Administrator Fees Payable Current And Noncurrent AdministratorFeesPayableCurrentAndNoncurrent	82936
CY2022Q4	ssic	Administrator Fees Payable Current And Noncurrent AdministratorFeesPayableCurrentAndNoncurrent	57306
CY2023Q1	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	72185
CY2022Q4	us-gaap	Accounts Payable Trade Current And Noncurrent AccountsPayableTradeCurrentAndNoncurrent	0
CY2023Q1	ssic	Audit Fees Payable Current And Noncurrent AuditFeesPayableCurrentAndNoncurrent	47883
CY2022Q4	ssic	Audit Fees Payable Current And Noncurrent AuditFeesPayableCurrentAndNoncurrent	50000
CY2023Q1	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	46936
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	28744
CY2023Q1	ssic	Directors Fee Payable Current And Noncurrent DirectorsFeePayableCurrentAndNoncurrent	35944
CY2022Q4	ssic	Directors Fee Payable Current And Noncurrent DirectorsFeePayableCurrentAndNoncurrent	32049
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	0
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	80566
CY2023Q1	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	0
CY2022Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	37
CY2023Q1	us-gaap	Other Liabilities OtherLiabilities	15515
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	33663
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	238419
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	0
CY2023Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	203821
CY2022Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	0
CY2023Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	142602
CY2022Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	0
CY2023Q1	us-gaap	Legal Fees LegalFees	98760
CY2022Q1	us-gaap	Legal Fees LegalFees	34069
CY2023Q1	ssic	Audit Fee Expense AuditFeeExpense	97883
CY2022Q1	ssic	Audit Fee Expense AuditFeeExpense	10000
CY2023Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	77844
CY2022Q1	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	47151
CY2023Q1	ssic	Valuation Fees Expense ValuationFeesExpense	73065
CY2022Q1	ssic	Valuation Fees Expense ValuationFeesExpense	0
CY2023Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	69082
CY2022Q1	us-gaap	General Insurance Expense GeneralInsuranceExpense	46488
CY2023Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	35944
CY2022Q1	us-gaap	Noninterest Expense Directors Fees NoninterestExpenseDirectorsFees	0
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	18192
CY2022Q1	us-gaap	Professional Fees ProfessionalFees	34920
CY2023Q1	us-gaap	Custody Fees CustodyFees	12000
CY2022Q1	us-gaap	Custody Fees CustodyFees	12000
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	0
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	34168
CY2023Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	19504
CY2022Q1	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	6808
CY2023Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	1087116
CY2022Q1	us-gaap	Investment Income Investment Expense InvestmentIncomeInvestmentExpense	225604
CY2023Q1	us-gaap-sup	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2022Q1	us-gaap-sup	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2022Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	ssic	Net Investment Income Loss Per Share Diluted NetInvestmentIncomeLossPerShareDiluted	0.22
CY2023Q1	ssic	Net Investment Income Loss Per Share Basic NetInvestmentIncomeLossPerShareBasic	0.22
CY2022Q1	ssic	Net Investment Income Loss Per Share Diluted NetInvestmentIncomeLossPerShareDiluted	-0.06
CY2022Q1	ssic	Net Investment Income Loss Per Share Basic NetInvestmentIncomeLossPerShareBasic	-0.06
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	86475729
CY2023Q1	us-gaap	Net Investment Income NetInvestmentIncome	1370723
CY2023Q1	us-gaap-sup	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2023Q1	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	2357080
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	0
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	2357080
CY2023Q1	ssic	Capital Effect Of Permanent Adjustments CapitalEffectOfPermanentAdjustments	0
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	88832809
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-507549
CY2022Q1	us-gaap	Net Investment Income NetInvestmentIncome	-215531
CY2022Q1	us-gaap-sup	Realized Gain Loss Investment And Derivative Operating After Tax RealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2022Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2022Q1	us-gaap	Investment Company Net Assets From Operations Increase Decrease InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease	-215531
CY2022Q1	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	1609184
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	85275170
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	85059639
CY2022Q1	ssic	Capital Effect Of Permanent Adjustments CapitalEffectOfPermanentAdjustments	0
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	84552090
CY2023Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	986357
CY2022Q1	us-gaap-sup	Unrealized Gain Loss Investment And Derivative Operating After Tax UnrealizedGainLossInvestmentAndDerivativeOperatingAfterTax	0
CY2023Q1	ssic	Increase Decrease In Capital Gains Incentive Fee Payable IncreaseDecreaseInCapitalGainsIncentiveFeePayable	142602
CY2022Q1	ssic	Increase Decrease In Capital Gains Incentive Fee Payable IncreaseDecreaseInCapitalGainsIncentiveFeePayable	0
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2023Q1	us-gaap	Investment Maturity Date InvestmentMaturityDate	2024-12-10
CY2023Q1	us-gaap	Investment Interest Rate InvestmentInterestRate	0.125
CY2023Q1	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	2000000
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	1798000
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1805000
CY2023Q1	us-gaap	Investment Owned Percent Of Net Assets InvestmentOwnedPercentOfNetAssets	0.0203
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2023-01-24
CY2023Q1	us-gaap-sup	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.0575
CY2023Q1	us-gaap-sup	Investment Interest Rate Floor InvestmentInterestRateFloor	0.0625
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-06-30
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-05-26
CY2023Q1	us-gaap-sup	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.085
CY2023Q1	us-gaap-sup	Investment Interest Rate Floor InvestmentInterestRateFloor	0.04
CY2023Q1	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-27
CY2023Q1	us-gaap-sup	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.065
CY2023Q1	us-gaap-sup	Investment Interest Rate Floor InvestmentInterestRateFloor	0.0625
CY2022	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.06
CY2022	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-11
CY2022	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-06-30
CY2022	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-05-26
CY2022Q4	us-gaap-sup	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.085
CY2022Q4	us-gaap-sup	Investment Interest Rate Floor InvestmentInterestRateFloor	0.04
CY2022	us-gaap-sup	Investment Acquisition Date InvestmentAcquisitionDate	2022-10-27
CY2022Q4	us-gaap-sup	Investment Basis Spread Variable Rate InvestmentBasisSpreadVariableRate	0.065
CY2022Q4	us-gaap-sup	Investment Interest Rate Floor InvestmentInterestRateFloor	0.0625
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	32540000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35130000
CY2023Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2022Q4	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	0
CY2023Q1	us-gaap	Investments Fair Value Disclosure InvestmentsFairValueDisclosure	0
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2317020
CY2022Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	10073
CY2023Q1	us-gaap	Interest Receivable InterestReceivable	1568026
CY2022Q4	us-gaap	Interest Receivable InterestReceivable	1559081
CY2022Q1	us-gaap-sup	Fee Income FeeIncome	0
CY2023Q1	us-gaap-sup	Fee Income FeeIncome	0
CY2023Q1	ssic	Minimum Percentage Of Ordinary Income MinimumPercentageOfOrdinaryIncome	0.98
CY2023Q1	ssic	Minimum Percentage Of Capital Gains MinimumPercentageOfCapitalGains	0.982
CY2023Q1	ssic	Percentage Of Taxable Income And Gain Distributed By Company PercentageOfTaxableIncomeAndGainDistributedByCompany	0.90
CY2023Q1	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.04
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	0
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current And Noncurrent SalesAndExciseTaxPayableCurrentAndNoncurrent	80566
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2023Q1	ssic	Organizational Expenses OrganizationalExpenses	0
CY2022Q1	ssic	Organizational Expenses OrganizationalExpenses	34168
CY2022Q4	ssic	Organizational Costs Payable Current And Noncurrent OrganizationalCostsPayableCurrentAndNoncurrent	0
CY2023Q1	ssic	Organizational Costs Payable Current And Noncurrent OrganizationalCostsPayableCurrentAndNoncurrent	0
CY2022Q1	ssic	Offering Costs Charged To Capital OfferingCostsChargedToCapital	1690184
CY2023Q1	ssic	Offering Costs Charged To Capital OfferingCostsChargedToCapital	0
CY2022Q4	ssic	Offering Cost Payable Current And Noncurrent OfferingCostPayableCurrentAndNoncurrent	0
CY2023Q1	ssic	Offering Cost Payable Current And Noncurrent OfferingCostPayableCurrentAndNoncurrent	0
CY2023Q1	ssic	Percent Of Portfolio That Is Variable Rate PercentOfPortfolioThatIsVariableRate	0.823
CY2023Q1	ssic	Percent Of Portfolio That Is Fixed Rate PercentOfPortfolioThatIsFixedRate	0.177
CY2022Q1	ssic	Percent Of Portfolio That Is Variable Rate PercentOfPortfolioThatIsVariableRate	0.809
CY2022Q1	ssic	Percent Of Portfolio That Is Fixed Rate PercentOfPortfolioThatIsFixedRate	0.191
CY2023Q1	ssic	Investment Owned Loan Repayment Period InvestmentOwnedLoanRepaymentPeriod	P3Y
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	54910290
CY2023Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	55623299
CY2023Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	142602
CY2022Q1	ssic	Capital Gains Incentive Fee Expense CapitalGainsIncentiveFeeExpense	0
CY2023Q1	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	142602
CY2022Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50527898
CY2022Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2022Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	50254550
CY2022Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	54910290
CY2023Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	55623299
CY2023Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50527898
CY2022Q4	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	50254550
CY2022Q4	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q1	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	54910290
CY2023Q1	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	55623299
CY2023Q1	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	50527898
CY2022Q4	ssic	Investment Owned At Cost Percentage InvestmentOwnedAtCostPercentage	1
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	50254550
CY2022Q4	ssic	Equity Securities Fair Value Percentage EquitySecuritiesFairValuePercentage	1
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	55623299
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	50254550
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	50254550
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	4230000
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Discount And Fees Net FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfDiscountAndFeesNet	140819
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Paid In Kind Interest Investment FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPaidInKindInterestInvestment	11573
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	0
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Proceeds From Principal Repayments Of Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetProceedsFromPrincipalRepaymentsOfInvestments	0
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Realized Gain Loss On Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetRealizedGainLossOnInvestments	0
CY2023Q1	ssic	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Net Change In Unrealized Appreciation Or Depreciation From Investments FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisNetChangeInUnrealizedAppreciationOrDepreciationFromInvestments	986357
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	55623299
CY2023Q1	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	986357
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
CY2023Q1	us-gaap	Management Fee Expense ManagementFeeExpense	238419
CY2022Q1	us-gaap	Management Fee Expense ManagementFeeExpense	0
CY2023Q1	us-gaap	Management Fee Payable ManagementFeePayable	409384
CY2022Q4	us-gaap	Management Fee Payable ManagementFeePayable	170965
CY2023Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	203821
CY2022Q1	ssic	Income Based Incentive Fee Expense IncomeBasedIncentiveFeeExpense	0
CY2023Q1	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	203821
CY2022Q4	ssic	Income Based Incentive Fee Payable IncomeBasedIncentiveFeePayable	0
CY2022Q4	ssic	Capital Gains Incentive Fee Payable CapitalGainsIncentiveFeePayable	0
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3557529
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3557529
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6214672
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214672
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214672
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6214672
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	85000000
CY2023Q1	us-gaap	Noninterest Expense Offering Cost NoninterestExpenseOfferingCost	2000000
CY2023Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0
CY2022Q1	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	0
CY2023Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2357080
CY2022Q1	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	-215531
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6214672
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6214672
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2023Q1	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	0
CY2023Q1	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	0
CY2022Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3418714
CY2023Q1	us-gaap	Tax Basis Of Investments Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet	713009
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	-399948
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	3731775
CY2023Q1	ssic	Tax Basis Of Investments And Cash Equivalents Cost For Income Tax Purposes TaxBasisOfInvestmentsAndCashEquivalentsCostForIncomeTaxPurposes	87454317
CY2022Q4	ssic	Tax Basis Of Investments And Cash Equivalents Cost For Income Tax Purposes TaxBasisOfInvestmentsAndCashEquivalentsCostForIncomeTaxPurposes	85653218
CY2023Q1	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	713009
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Appreciation TaxBasisOfInvestmentsGrossUnrealizedAppreciation	0
CY2023Q1	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	0
CY2022Q4	us-gaap	Tax Basis Of Investments Gross Unrealized Depreciation TaxBasisOfInvestmentsGrossUnrealizedDepreciation	273348
CY2023Q1	ssic	Tax Basis Of Investments And Cash Equivalents Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsAndCashEquivalentsUnrealizedAppreciationDepreciationNet	713009
CY2022Q4	ssic	Tax Basis Of Investments And Cash Equivalents Unrealized Appreciation Depreciation Net TaxBasisOfInvestmentsAndCashEquivalentsUnrealizedAppreciationDepreciationNet	-273348
CY2022Q4	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.91
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14
CY2023Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	0.22
CY2022Q1	us-gaap	Investment Company Investment Income Loss Per Share InvestmentCompanyInvestmentIncomeLossPerShare	-0.07
CY2023Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0.16
CY2022Q1	us-gaap	Investment Company Gain Loss On Investment Per Share InvestmentCompanyGainLossOnInvestmentPerShare	0
CY2023Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	0.38
CY2022Q1	us-gaap	Investment Company Net Asset Value Per Share Period Increase Decrease InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease	-0.07
CY2023Q1	ssic	Investment Company Offering Costs Per Share InvestmentCompanyOfferingCostsPerShare	0
CY2022Q1	ssic	Investment Company Offering Costs Per Share InvestmentCompanyOfferingCostsPerShare	-0.27
CY2023Q1	ssic	Investment Company Permanent Tax Adjustments Per Share InvestmentCompanyPermanentTaxAdjustmentsPerShare	0
CY2022Q1	ssic	Investment Company Permanent Tax Adjustments Per Share InvestmentCompanyPermanentTaxAdjustmentsPerShare	-0.05
CY2023Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	14.29
CY2022Q1	us-gaap	Net Asset Value Per Share NetAssetValuePerShare	13.61
CY2023Q1	us-gaap	Assets Net AssetsNet	88832809
CY2022Q1	us-gaap	Assets Net AssetsNet	84552090
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214672
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6214672
CY2023Q1	ssic	Weighted Average Net Assets WeightedAverageNetAssets	86501919
CY2022Q1	ssic	Weighted Average Net Assets WeightedAverageNetAssets	83301328
CY2023Q1	ssic	Per Share Market Value PerShareMarketValue	9.19
CY2022Q1	ssic	Per Share Market Value PerShareMarketValue	13.3
CY2023Q1	ssic	Investment Company Total Return On Market Value InvestmentCompanyTotalReturnOnMarketValue	-0.0622
CY2022Q1	ssic	Investment Company Total Return On Market Value InvestmentCompanyTotalReturnOnMarketValue	-0.05
CY2023Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	0.0273
CY2022Q1	us-gaap	Investment Company Total Return InvestmentCompanyTotalReturn	-0.0279
CY2023Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0126
CY2022Q1	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.0022
CY2023Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	0.0158
CY2022Q1	us-gaap	Investment Company Investment Income Loss Ratio InvestmentCompanyInvestmentIncomeLossRatio	-0.002

Files In Submission

Name	View Source	Status
0001140361-23-024271-index-headers.html	Edgar Link	pending
0001140361-23-024271-index.html	Edgar Link	pending
0001140361-23-024271.txt	Edgar Link	pending
0001140361-23-024271-xbrl.zip	Edgar Link	pending
brhc20052248_10q.htm	Edgar Link	pending
brhc20052248_ex31-1.htm	Edgar Link	pending
brhc20052248_ex31-2.htm	Edgar Link	pending
brhc20052248_ex32-1.htm	Edgar Link	pending
brhc20052248_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
brhc20052248_10q_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ssic-20230331.xsd	Edgar Link	pending
ssic-20230331_cal.xml	Edgar Link	unprocessable
ssic-20230331_def.xml	Edgar Link	unprocessable
ssic-20230331_lab.xml	Edgar Link	unprocessable
ssic-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LIEN
Chicago Atlantic BDC, Inc. Stock $lien

2023 Q2 Form 10-Q Financial Statement

#000114036123024271 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIEN Chicago Atlantic BDC, Inc. Stock $lien

2023 Q2 Form 10-Q Financial Statement

#000114036123024271 Filed on May 12, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LIEN
Chicago Atlantic BDC, Inc. Stock $lien